{"schemaVersion":"1.0","generatedFrom":"https://brightaifuture.com/discoveries/sierra-leone-medicine-allocation","record":{"id":"sierra-leone-medicine-allocation","headline":"A medicine budget aimed where it could do more.","canonicalUrl":"https://brightaifuture.com/discoveries/sierra-leone-medicine-allocation","datePublished":"2026-09-19","dateModified":null,"sourcePublicationDate":"2026-04-29","author":null,"publisher":{"name":"Bright AI Future","url":"https://brightaifuture.com/"},"topics":[],"summary":"Researchers modeled medicine allocation in Sierra Leone and tested the approach in five of 16 districts, estimating a 19% increase in consumption from the available supply and describing a path to national allocation for roughly two million women and children under five.","evidenceState":"Demonstrated","keyFacts":[{"label":"AI’s role","value":"An optimization system used available health and supply information to recommend allocations under budget and logistics constraints."},{"label":"Documented result","value":"The Nature paper reports a five-district evaluation and an estimated 19% increase in medicine consumption; the authors report national-scale computation costing about US$30 per month. The national two-million-person figure describes intended reach, not a measured health outcome."},{"label":"Important limitation","value":"The field work covered five of Sierra Leone's 16 districts."}],"limitations":["The field work covered five of Sierra Leone's 16 districts.","Medicine consumption is not the same as improved health, and the 19% figure is a Synthetic Difference-in-Differences estimate from the five-district pilot rather than a randomized health-outcome result.","National scaling still depends on procurement, transport, data quality, and local judgment."],"evidenceLinks":[{"title":"Improving access to essential medicines via decision-aware machine learning","url":"https://www.nature.com/articles/s41586-026-10433-7","type":"paper"},{"title":"Improving Access to Essential Medicines via Decision-Aware Machine Learning","url":"https://arxiv.org/abs/2607.20542","type":"paper"}],"evidencePackUrl":"https://brightaifuture.com/evidence-pack/sierra-leone-medicine-allocation","embedUrl":"https://brightaifuture.com/embed/story/sierra-leone-medicine-allocation","attribution":{"credit":"Bright AI Future","requirements":["Link to the canonical Bright record.","Keep material limitations with the claim they qualify.","Link to the original evidence when repeating a substantive claim.","Do not describe a source check or organization-reported result as independent verification."],"sourceRights":"Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media."}},"claim":{"humanProblem":"Scarce essential medicines can be distributed unevenly, leaving some clinics without enough stock while needs differ across districts.","priorConstraint":"Allocation decisions had limited timely demand data and had to balance many medicines, facilities, and constraints.","aiRole":"An optimization system used available health and supply information to recommend allocations under budget and logistics constraints.","documentedResult":"The Nature paper reports a five-district evaluation and an estimated 19% increase in medicine consumption; the authors report national-scale computation costing about US$30 per month. The national two-million-person figure describes intended reach, not a measured health outcome.","whyItMayMatter":"Better allocation can make a fixed public budget more useful without pretending software creates medicines, transport, or clinical capacity.","unresolvedQuestions":["Do stock availability and patient outcomes improve after national use?","How robust are recommendations when demand or inventory data are incomplete?","How can district staff override or contest an allocation?"]},"evidenceAssessment":{"state":"Demonstrated","claimConfidence":"high","reviewState":"approved","reviewMethod":"ai-assisted","reviewNote":"AI-assisted editorial comparison with the cited primary sources, explicit evidence limits, and held alternatives. Publication authorized by the site owner on 2026-09-19; no human source review or independent replication is claimed.","lastSourceReview":"2026-09-19","independentVerification":"not-established-by-this-source-review"},"sources":[{"id":"source-sl-medicines-nature","title":"Improving access to essential medicines via decision-aware machine learning","url":"https://www.nature.com/articles/s41586-026-10433-7","type":"paper"},{"id":"source-sl-medicines-preprint","title":"Improving Access to Essential Medicines via Decision-Aware Machine Learning","url":"https://arxiv.org/abs/2607.20542","type":"paper"}],"revisions":[{"id":"revision:sept26-sl-medicines-01","recordedAt":"2026-09-19","summary":"Initial draft separates measured deployment scope from national projection.","sourceIds":["source-sl-medicines-nature","source-sl-medicines-preprint"]}],"corrections":[]}